Trials / Completed
CompletedNCT00074841
Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India
A Phase II/III, Randomized, Comparative Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in India
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 230 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This primary objective of this study is to assess whether the combination of Azithromycin with chloroquine is non-inferior to the combination of sulfadoxine-pyrimethamine plus chloroquine, when used to treat uncomplicated cases of malaria due to Plasmodium falciparum in adults in India.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin/Chloroquine | |
| DRUG | Sulfadoxine-Pyrimethamine/Chloroquine |
Timeline
- Start date
- 2003-09-01
- Completion
- 2005-01-01
- First posted
- 2003-12-24
- Last updated
- 2011-05-10
Locations
7 sites across 1 country: India
Source: ClinicalTrials.gov record NCT00074841. Inclusion in this directory is not an endorsement.